Medicare Part D Coverage by Drug
Medicare's drug benefit is sold by private plans, and each plan keeps a list of the drugs it pays for, called a formulary. This counts how many plans list a drug, which price tier they put it on, and how many make patients get approval first or try another drug first.
Pick a drug to see how many of Medicare's 5,496 Part D plans cover it, the tiers they put it on, and how many require prior authorization, step therapy or a quantity limit, by plan type and state. From CMS's formulary file for Q3 2026.
- Part D plans: 5,496
- Formularies they use: 328
- Drugs on at least one: 2,217
- Covered by every plan: 699
Brands Most Often Needing Prior Authorization
Share of covering plans that require it; brands at least half of plans cover.
Brands Most Often Needing Step Therapy
Share of covering plans that require trying another drug first; brands at least a quarter of plans cover.
Every Drug on a Part D Formulary
Share of 5,496 plans that cover each drug, and of those, the share that restrict it. Open one for its tiers and plans.2,217 drugs
| abacavir | 100% | 0% | 0% | 55% |
| abacavir / lamivudine | 100% | 0% | 0% | 55% |
| Abilifyaripiprazole | 100% | 2% | 1% | 92% |
| Abrysvorespiratory syncytial virus pre-fusion F protein | 100% | 44% | 0% | 51% |
| acamprosate | 100% | 0% | 0% | 0% |
| acarbose | 100% | 0% | 0% | 59% |
| acetaminophen / codeine | 100% | 2% | 0% | 96% |
| acetaminophen / hydrocodone | 100% | 2% | 0% | 96% |
| acetaminophen / oxycodone | 100% | 2% | 0% | 96% |
| acetazolamide | 100% | 0% | 0% | 0% |
| acitretin | 100% | 59% | 0% | 0% |
| ActHIBHaemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine | 100% | 0% | 0% | 15% |
| Actimmuneinterferon gamma-1b | 100% | 81% | 0% | 0% |
| acyclovir | 100% | 97% | 0% | 44% |
| Adacelacellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated | 100% | 0% | 0% | 16% |
| Adempasriociguat | 100% | 100% | 0% | 79% |
| Akeegaabiraterone / niraparib | 100% | 98% | 0% | 91% |
| albendazole | 100% | 12% | 0% | 29% |
| albuterol | 100% | 100% | 0% | 75% |
| albuterol / ipratropium | 100% | 100% | 0% | 12% |
| Alecensaalectinib | 100% | 98% | 0% | 92% |
| alendronate | 100% | 0% | 5% | 79% |
| alfuzosin | 100% | 0% | 0% | 38% |
| aliskiren | 100% | 0% | 0% | 39% |
| allopurinol | 100% | 0% | 0% | 0% |
| alosetron | 100% | 89% | 0% | 66% |
| Alunbrigbrigatinib | 100% | 98% | 0% | 95% |
| amantadine | 100% | 0% | 0% | 27% |
| amikacin | 100% | 8% | 0% | 0% |
| amiloride | 100% | 0% | 0% | 0% |
| amiodarone | 100% | 0% | 0% | 0% |
| amitriptyline | 100% | 51% | 0% | 0% |
| amlodipine | 100% | 0% | 0% | 0% |
| amlodipine / benazepril | 100% | 0% | 0% | 48% |
| amoxapine | 100% | 34% | 0% | 0% |
| amoxicillin | 100% | 0% | 0% | 0% |
| amoxicillin / clavulanate | 100% | 0% | 0% | 0% |
| amphetamine / dextroamphetamine | 100% | 19% | 0% | 93% |
| amphotericin B | 100% | 98% | 0% | 0% |
| ampicillin | 100% | 8% | 0% | 0% |
| ampicillin / sulbactam | 100% | 7% | 0% | 0% |
| anagrelide | 100% | 0% | 0% | 0% |
| anastrozole | 100% | 0% | 0% | 19% |
| aprepitant | 100% | 100% | 0% | 49% |
| Aptivustipranavir | 100% | 0% | 0% | 55% |
| Arexvyrespiratory syncytial virus pre-fusion F protein | 100% | 44% | 0% | 51% |
| Arikayceamikacin | 100% | 94% | 0% | 29% |
| aripiprazole | 100% | 10% | 16% | 93% |
| asenapine | 100% | 27% | 1% | 95% |
| atazanavir | 100% | 0% | 0% | 55% |
Every Medicare Part D plan on CMS's quarterly public use file (5,496 stand-alone, Medicare Advantage and special needs plans, 328 formularies; employer-only and suppressed plans are not in it). Plans are counted equally, not by enrollment, which CMS does not publish in this file. A drug is a brand (all its strengths and forms) or a generic ingredient, grouped from each formulary's RxNorm codes with NLM's RxNorm prescribable content. A plan covers a drug when its formulary lists any of those codes; its tier is the lowest one listed, and a restriction counts when any form carries it. Plans name their own tiers; most use 1 for preferred generics, 2 generics, 3 preferred brands, 4 non-preferred drugs and 5 specialty drugs. Regional and stand-alone plans count in every state of their region. Refreshed weekly; CMS posts a new file each quarter. CMS, Prescription Drug Plan Formulary, Pharmacy Network and Pricing Information, Q3 2026